ARIS
LLY icon

Advanced Research Investment Solutions’s Eli Lilly LLY Stock Holding History

Advanced Research Investment Solutions’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-40
Closed -$11K – 230
2021
Q4 		$11K Buy
+40
New +$10.1K ﹤0.01% 132

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Advanced Research Investment Solutions's LLY Position: Q1 2022 in Review

Advanced Research Investment Solutions sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 40 shares — an estimated $11K sold.

Advanced Research Investment Solutions first reported a position in LLY in Q4 2021 and held it in 1 quarter. The position peaked at $11K in Q4 2021. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Advanced Research Investment Solutions reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
  • Advanced Research Investment Solutions sold 40 Eli Lilly shares in Q1 2022, an estimated $11K.
  • Advanced Research Investment Solutions first reported a position in Eli Lilly in Q4 2021 and held it in 1 quarter.
  • Advanced Research Investment Solutions's Eli Lilly position peaked at $11K in Q4 2021.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Advanced Research Investment Solutions's 13F filing for Q1 2022, filed 10 May 2022.